The shared and distinct cistromes of YAP and TAZ in melanoma
Project Number1R03CA288281-01A1
Former Number1R03CA288281-01
Contact PI/Project LeaderLANG, DEBORAH
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Abstract
Melanoma is the most lethal of all skin cancers due to the high degree of metastasis. Our group and others find
the transcriptional co-factors and paralogs YAP and TAZ active in melanoma progression, invasion, and
metastasis. Although YAP and TAZ are often thought of as redundant, we discovered differential functions in
melanoma cells: both factors effect cell growth, while YAP was the dominant paralog driving migration, focal
adhesion numbers, and invasion. While YAP and TAZ do not directly bind to DNA, they modulate gene
expression by cooperating with transcription factors. While some of these factors interact with both YAP and
TAZ, there are likely other transcriptional regulators with higher affinity for either YAP or TAZ. Further supporting
that YAP and TAZ are not interchangeable, we found overlapping but distinct YAP and TAZ transcriptomes, and
identified a YAP-specific gene, ARPC5, which promoted migration through changes to the cytoskeleton and focal
adhesions. The question remains on what the redundant and unique roles of YAP and TAZ are, and what is the
mechanism for divergent roles in terms of cofactors, downstream target genes, and functional consequences.
The hypothesis guiding this proposal is that YAP and TAZ have similar and divergent transcriptional downstream
targets that regulate overlapping and unique cellular processes. To support this hypothesis, we performed non-
biased transcriptional and enhancer screens for YAP and TAZ locations on the genome, and revealed that YAP
and TAZ have shared and distinct cistromic signatures. Indeed, we discovered significant similarities and
differences in both cellular expression signatures as well as cistromic patterns. Our general strategy is to
examine identified genes and enhancer regions to reveal YAP and/or TAZ transcriptional partners and
downstream gene targets. Our research plan will utilize bioinformatic prediction and applied functional assays
to reveal molecular pathways and downstream consequences of YAP and/or TAZ function in melanoma. The
goal of this proposal is to make impactful discoveries on YAP and TAZ downstream genetic targets and to identify
their function in terms of tumorigenic processes. Our work is significant and impactful since these studies will
uncover unique transcriptional pathways where YAP and TAZ function separately, redundantly, or together, and
may reveal new potential molecular weak points in tumor progression that can be targeted by therapeutics. This
proposal is innovative since the YAP/TAZ transcriptional roles in melanoma, as well as specific genetic targets
and functional consequences, are mostly unknown.
Public Health Relevance Statement
Narrative
The goal of this proposal is to make impactful discoveries on the overlapping and unique functions of YAP and
TAZ proteins on regulating gene expression in melanoma. YAP and TAZ are implicated in driving melanoma
aggressiveness and metastasis, which are the predominant causes of patient morbidity and mortality. We will
establish a method for identifying cancer-driving genes that are regulated by YAP and TAZ, as well as regions
in the DNA that modulate the function of these genes.
No Sub Projects information available for 1R03CA288281-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03CA288281-01A1
Patents
No Patents information available for 1R03CA288281-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03CA288281-01A1
Clinical Studies
No Clinical Studies information available for 1R03CA288281-01A1
News and More
Related News Releases
No news release information available for 1R03CA288281-01A1
History
No Historical information available for 1R03CA288281-01A1
Similar Projects
No Similar Projects information available for 1R03CA288281-01A1